Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guide
- PDF / 9,606,485 Bytes
- 33 Pages / 595.276 x 790.866 pts Page_size
- 64 Downloads / 149 Views
POSITION ARTICLE AND GUIDELINES
Open Access
Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline (updated version) Ying-Hui Jin1, Qing-Yuan Zhan2,3, Zhi-Yong Peng4,5, Xue-Qun Ren6, Xun-Tao Yin7, Lin Cai4,8, Yu-Feng Yuan4,9, Ji-Rong Yue10,11, Xiao-Chun Zhang4,12, Qi-Wen Yang13, Jianguang Ji14, Jian Xia4,15, Yi-Rong Li4,16, Fu-Xiang Zhou17, Ya-Dong Gao16, Zhui Yu18, Feng Xu19, Ming-Li Tu20, Li-Ming Tan21, Min Yang22, Fang Chen23, Xiao-Ju Zhang24, Mei Zeng25, Yu Zhu26, Xin-Can Liu27, Jian Yang28, Dong-Chi Zhao29, Yu-Feng Ding30, Ning Hou31, Fu-Bing Wang16, Hao Chen32, Yong-Gang Zhang10,33, Wei Li34, Wen Chen35, Yue-Xian Shi36, Xiu-Zhi Yang37, Xue-Jun Wang38, Yan-Jun Zhong39, Ming-Juan Zhao1, Bing-Hui Li1,6,40, Lin-Lu Ma1,41, Hao Zi1,6, Na Wang6,42, Yun-Yun Wang1, Shao-Fu Yu1,21, Lu-Yao Li1,6, Qiao Huang1, Hong Weng1,40, Xiang-Ying Ren1,6,42, Li-Sha Luo1, Man-Ru Fan1, Di Huang1, Hong-Yang Xue1, Lin-Xin Yu1, Jin-Ping Gao1,43, Tong Deng1,6, Xian-Tao Zeng1,4* , Hong-Jun Li44*, Zhen-Shun Cheng4,45*, Xiaomei Yao46*, Xing-Huan Wang1,4,40*, Evidence-Based Medicine Chapter of China International Exchange and Promotive Association for Medical and Health Care (CPAM) and Chinese Research Hospital Association (CRHA)
Abstract The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of a rapidly spreading illness, coronavirus disease 2019 (COVID-19), affecting more than seventeen million people around the world. Diagnosis and treatment guidelines for clinicians caring for patients are needed. In the early stage, we have issued “A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)”; now there are many direct evidences emerged and may change some of previous recommendations and it is ripe for develop an evidence-based guideline. We formed a working group of clinical experts and methodologists. The steering group members proposed 29 questions that are relevant to the (Continued on next page)
* Correspondence: [email protected]; [email protected]; [email protected]; [email protected]; [email protected] 1 Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China 44 Department of Diagnostic Radiology, Beijing You’an Hospital, Capital Medical University, Beijing 100069, China 4 Leishenshan Hospital in Wuhan, Wuhan 430200, China 46 Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario L8S 4L8, Canada Full list of author information is available at the end of the article © The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
Data Loading...
